ILCA Webinar Series

HomeEducationILCA Webinar Series

Keep Your Knowledge Relevant to Liver Cancer Research and Treatment

ILCA offers a full range of online educational programmes delivered by scientific and medical experts from around the world exchanging the latest scientific advances and best practices in liver cancer research and care.

On-Demand Webinars

Primary and acquired resistance to immunotherapy in HCC: From research to practice

Thursday 11 November, 2021

  • How can animal models help better understand primary and secondary resistance to immune checkpoint inhibitor therapy
  • Combination Strategies to Address Immune Checkpoint Inhibitor Resistance in Advanced HCC
  • Insight from neoadjuvant and adjuvant trials of immunotherapy

Systemic therapy of CCA. Patho-molecular profile meets treatment choices

Monday 27 September, 2021

  • Pathology of CCA
  • Molecular characterization, actionable genetic alterations
  • Targeted therapies including immunotherapy given recent promising early phase data with lenva-pembro or IO+chemo and ongoing phase 2-3 trials
ILCA Webinar Series

Radiation oncology in the management of HCC. Who and how should be treated.

Thursday 17th June, 2021
Duration: 1 hour

Best of ILCA 2020

As 2021 gets into gear, ILCA’s liver cancer experts present this webinar based on key selected sessions of the ILCA 2020 Annual Conference.

Thursday 25th February, 2021
Duration: 1 hour

Management Of Hcc During Covid-19: ILCA Guidance

Our expert presenters discussed the current data on COVID-19-related liver disease and the impact of SARS-CoV-2 infection in patients with chronic liver diseases.

Friday 17th April, 2020
Duration: 1 hour

  • ILCA Single Topic Workshop. 9-10 June, 2022.
  • ILCA Annual Conference 2022. 1-4 September, 2022.